From January 31, 2023 to January 31, 2023, the company has repurchased 468,308 shares, representing 2.57% for $1.4 million. With this, the company has completed the repurchase of 468,308 shares, representing 2.57% for $1.4 million under the buyback announced on February 2, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | 0.00% | -0.47% | -1.85% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.85% | 17.92M | |
+32.41% | 664B | |
+29.29% | 567B | |
-7.32% | 354B | |
+19.31% | 330B | |
+4.73% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-5.00% | 148B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.